Cisatracurium Besylate is used for inducing muscle relaxation during surgical procedures. It was first introduced by Abbvie Inc in its drug Nimbex Preservative Free on Dec 15, 1995. Another drug containing Cisatracurium Besylate is Nimbex. 17 different companies have introduced drugs containing Cisatracurium Besylate.
Cisatracurium Besylate Patents
Given below is the list of patents protecting Cisatracurium Besylate, along
with the drug name that holds that patent and the company name owning that
drug.
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List
Cisatracurium Besylate Generic API Manufacturers
Several generic applications have been filed for Cisatracurium Besylate. The first generic version for Cisatracurium Besylate was by Sandoz Inc and was approved on Feb 3, 2012. And the latest generic version is by Hainan Poly Pharm Co Ltd and was approved on Aug 27, 2024.
Given below is the list of companies who have filed for
Cisatracurium Besylate generic, along with the locations of their manufacturing plants worldwide.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 2 different strengths of generic version for Cisatracurium Besylate. All of these versions come by the name CISATRACURIUM BESYLATE PRESERVATIVE FREE. Given below are the
details of the strengths of this generic introduced by
Accord Hlthcare.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 10MG BASE/ML
injectable
Discontinued
INJECTION
N/A
Jun 16, 2017
EQ 2MG BASE/ML
injectable
Discontinued
INJECTION
N/A
Jun 16, 2017
2. CAPLIN
Caplin Steriles Ltd has filed for 2 different strengths of generic version for Cisatracurium Besylate. Given below are the
details of the strengths of this generic introduced by
Caplin.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 10MG BASE/ML
injectable
Discontinued
INJECTION
N/A
Jun 9, 2023
EQ 2MG BASE/ML
injectable
Discontinued
INJECTION
N/A
Jun 9, 2023
Manufacturing Plant Locations
New
Caplin's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Caplin as present at those locations.
Country
City
Firm Name
United States
Creve Coeur
Caplin, Dr David
India
Gummidipoondi
Caplin Steriles Limited
3. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 1 generic for Cisatracurium Besylate. This eq 2mg base/ml version comes by the name CISATRACURIUM BESYLATE PRESERVATIVE FREE. Given below are the
details of the strengths of this generic introduced by
Eugia Pharma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 2MG BASE/ML
injectable
Prescription
INJECTION
AP
Oct 27, 2020
Manufacturing Plant Locations
New
Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.
Country
City
Firm Name
India
Pashamylaram
Eugia Pharma Specialities Limited
Medchal-Malkajgiri District
EUGIA Pharma Specialities Limited
Riico Industrial Area
EUGIA Pharma Specialities Limited
4. FRESENIUS KABI USA
Fresenius Kabi Usa Llc has filed for 2 different strengths of generic version for Cisatracurium Besylate. All of these versions come by the name CISATRACURIUM BESYLATE PRESERVATIVE FREE. Given below are the
details of the strengths of this generic introduced by
Fresenius Kabi Usa.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 2MG BASE/ML
injectable
Prescription
INJECTION
AP
Feb 26, 2015
EQ 10MG BASE/ML
injectable
Prescription
INJECTION
AP
Feb 26, 2015
Manufacturing Plant Locations
New
Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.
Country
City
Firm Name
United States
Melrose Park
Fresenius Kabi USA, LLC
Wilson
Fresenius Kabi USA, LLC
Skokie
Fresenius Kabi USA LLC
Grand Island
Fresenius Kabi USA, LLC
North Andover
Fresenius Kabi USA, LLC
Bensenville
Fresenius Kabi USA LLC (FK USA)
Melrose Park
Fresenius Kabi USA LLC
Lake Zurich
Fresenius Kabi USA, LLC
5. HAINAN POLY
Hainan Poly Pharm Co Ltd has filed for 2 different strengths of generic version for Cisatracurium Besylate. All of these versions come by the name CISATRACURIUM BESYLATE PRESERVATIVE FREE. Given below are the
details of the strengths of this generic introduced by
Hainan Poly.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 2MG BASE/ML
injectable
Prescription
INJECTION
AP
Aug 27, 2024
EQ 10MG BASE/ML
injectable
Prescription
INJECTION
AP
Aug 27, 2024
Manufacturing Plant Locations
New
Hainan Poly's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Hainan Poly as present at those locations.
Country
City
Firm Name
China
Haikou
Hainan Poly Pharm. Co., Ltd.
6. HENGRUI PHARMA
Jiangsu Hengrui Pharmaceuticals Co Ltd has filed for 2 different strengths of generic version for Cisatracurium Besylate. Out of these eq 10mg base/ml version comes by the name CISATRACURIUM BESYLATE PRESERVATIVE FREE. Given below are the
details of the strengths of this generic introduced by
Hengrui Pharma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 2MG BASE/ML
injectable
Prescription
INJECTION
AP
Aug 30, 2017
EQ 10MG BASE/ML
injectable
Prescription
INJECTION
AP
Sep 19, 2017
7. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Cisatracurium Besylate. Given below are the
details of the strengths of this generic introduced by
Hikma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 2MG BASE/ML
injectable
Prescription
INJECTION
AP
Apr 19, 2023
EQ 10MG BASE/ML
injectable
Prescription
INJECTION
AP
Dec 18, 2023
Manufacturing Plant Locations
New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
Country
City
Firm Name
United States
Eatontown
Hikma Pharmaceuticals USA, Inc.
Cherry Hill
Hikma Pharmaceuticals USA Inc.
Dayton
Hikma Injectables USA Inc
Carlsbad
Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Portugal
Terrugem Snt
Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman
Hikma Pharmaceuticals LLC
8. HOSPIRA
Hospira Inc has filed for 2 different strengths of generic version for Cisatracurium Besylate. Given below are the
details of the strengths of this generic introduced by
Hospira.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 2MG BASE/ML
injectable
Prescription
INJECTION
AP
Mar 30, 2018
EQ 10MG BASE/ML
injectable
Prescription
INJECTION
AP
Mar 30, 2018
Manufacturing Plant Locations
New
Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.
Country
City
Firm Name
Australia
Mulgrave
Hospira Australia Pty Ltd.
United States
Rocky Mount
Hospira, Inc.
Clayton
Hospira, Inc.
Morgan Hill
Hospira Inc
Mcpherson
Hospira, Inc., A Pfizer Company
Lake Forest
Hospira Inc
Pleasant Prairie
Hospira Worldwide, LLC d.b.a. Hospira, a Pfizer-owned Company
Dominican Republic (the)
Haina, San Cristobal
Hospira, Ltd.
9. MEITHEAL
Meitheal Pharmaceuticals Inc has filed for 2 different strengths of generic version for Cisatracurium Besylate. Given below are the
details of the strengths of this generic introduced by
Meitheal.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 2MG BASE/ML
(reference standard)
injectable
Prescription
INJECTION
AP
Apr 25, 2019
EQ 10MG BASE/ML
(reference standard)
injectable
Prescription
INJECTION
AP
Apr 25, 2019
10. PIRAMAL
Piramal Healthcare Uk Ltd has filed for 2 different strengths of generic version for Cisatracurium Besylate. Given below are the
details of the strengths of this generic introduced by
Piramal.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 2MG BASE/ML
injectable
Discontinued
INJECTION
N/A
Mar 11, 2022
EQ 10MG BASE/ML
injectable
Discontinued
INJECTION
N/A
Mar 11, 2022
11. PIRAMAL CRITICAL
Piramal Critical Care Inc has filed for 2 different strengths of generic version for Cisatracurium Besylate. Given below are the
details of the strengths of this generic introduced by
Piramal Critical.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 10MG BASE/ML
injectable
Prescription
INJECTION
AP
May 24, 2022
EQ 2MG BASE/ML
injectable
Prescription
INJECTION
AP
Dec 14, 2022
Manufacturing Plant Locations
New
Piramal Critical's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Piramal Critical as present at those locations.
Country
City
Firm Name
United States
Bethlehem
Piramal Critical Care, Inc.
12. SAGENT PHARMS INC
Sagent Pharmaceuticals Inc has filed for 2 different strengths of generic version for Cisatracurium Besylate. Given below are the
details of the strengths of this generic introduced by
Sagent Pharms Inc.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 2MG BASE/ML
injectable
Prescription
INJECTION
AP
Nov 6, 2020
EQ 10MG BASE/ML
injectable
Prescription
INJECTION
AP
Nov 6, 2020
13. SANDOZ INC
Sandoz Inc has filed for 2 different strengths of generic version for Cisatracurium Besylate. All of these versions come by the name CISATRACURIUM BESYLATE PRESERVATIVE FREE. Given below are the
details of the strengths of this generic introduced by
Sandoz Inc.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 2MG BASE/ML
injectable
Prescription
INJECTION
AP
Feb 3, 2012
EQ 10MG BASE/ML
injectable
Prescription
INJECTION
AP
Feb 3, 2012
Manufacturing Plant Locations
New
Sandoz Inc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Sandoz Inc as present at those locations.
Country
City
Firm Name
United States
Princeton
Sandoz Inc
East Hanover
Sandoz Incorporated
14. SOMERSET
Somerset Therapeutics Llc has filed for 1 generic for Cisatracurium Besylate. Given below are the
details of the strengths of this generic introduced by
Somerset.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 2MG BASE/ML
injectable
Prescription
INJECTION
AP
Apr 24, 2019
Manufacturing Plant Locations
New
Somerset's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Somerset as present at those locations.
Country
City
Firm Name
United States
Somerville
Somerset Medical Center IRB
Fairfield
Somerset Auction Company, LLC
India
Bengaluru
Somerset Therapeutics Limited
15. SOMERSET THERAPS LLC
Somerset Therapeutics Llc has filed for 2 different strengths of generic version for Cisatracurium Besylate. All of these versions come by the name CISATRACURIUM BESYLATE PRESERVATIVE FREE. Given below are the
details of the strengths of this generic introduced by
Somerset Theraps Llc.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
EQ 2MG BASE/ML
injectable
Prescription
INJECTION
AP
Feb 20, 2019
EQ 10MG BASE/ML
injectable
Prescription
INJECTION
AP
Feb 20, 2019
16. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Cisatracurium Besylate. Given below are the
details of the strengths of this generic introduced by
Zydus Pharms.
